Tübingen, Germany

Ingmar Hoerr

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 2.9

ph-index = 16

Forward Citations = 720(Granted Patents)


Location History:

  • Tubingen, DE (2012 - 2022)
  • Stuttgart, DE (2021 - 2023)
  • Tübingen, DE (2016 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovations of Ingmar Hoerr: A Leader in RNA Therapeutics

Introduction

Ingmar Hoerr is a prominent inventor based in Tübingen, Germany, credited with an impressive portfolio of 21 patents. His cutting-edge work is primarily focused on therapeutic innovations, particularly in the field of RNA therapeutics. Hoerr's contributions to science and medicine have the potential to revolutionize the way diseases are treated.

Latest Patents

Among his latest patents, Hoerr has developed an RNA encoding a therapeutic protein, which details the invention of RNA suitable for use as a medicament. This invention includes novel RNA compositions and kits designed to enhance the expression of the encoded protein, making it particularly relevant for applications in gene therapy.

Another significant patent relates to a composition for treating prostate cancer. This active immunostimulatory composition comprises at least one RNA, ideally an mRNA, encoding multiple antigens that can elicit an adaptive immune response. The antigens selected for this composition include Prostate-Specific Antigen (PSA), Prostate-Specific Membrane Antigen (PSMA), Prostate Stem Cell Antigen (PSCA), and STEAP (Six Transmembrane Epithelial Antigen of the Prostate). This invention further encompasses a vaccine utilizing this composition, aimed at eliciting immune responses for treating prostate cancer, particularly in advanced and hormone-refractory stages.

Career Highlights

Ingmar Hoerr has made significant strides in the biotechnology sector, particularly during his tenure at CureVac AG and CureVac SE, where he has played a pivotal role in RNA-based therapeutic development. His innovative approach to immunotherapy continues to influence the trajectory of cancer treatments and RNA technology.

Collaborations

Throughout his career, Hoerr has collaborated with notable scientists such as Steve Pascolo and Florian Von Der Mülbe. These partnerships have enabled groundbreaking advancements in understanding and harnessing the potential of RNA for therapeutic purposes.

Conclusion

Ingmar Hoerr stands out as a visionary inventor whose work is integral to the field of RNA therapeutics. His dedication to innovation and collaborative spirit continue to drive advancements that may one day transform patient care and treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…